Data News > Top gainers in Biotechnology and Gene Therapy - CRSP, EDIT, ALNY, REGN, LH
CRSP is trading UP for the last 2 days, and it at trading at $62.34 with volume of 1,770,869 and a one day change of $2.35 (3.92%). CRISPR Therapeutics AG has a 52-week low of 37.55 and a 52-week high of $91.10. The business's 50-day moving average price is $55.60 and its 200 day moving average price is $65.27. The firm has a market cap of $5 million, a P/E ratio of 14.17, and a beta of 1.78.
CRISPR Therapeutics AG (NASDAQ:CRSP ) Company Conference Call June 11, 2024 9:20 AM ET Company Participants Sam Kulkarni - Chief Executive Officer Conference Call Participants Salveen Richter - Goldman Sachs Salveen Richter Good afternoon everyone, thank you for joining us. Really pleased to have Sam Kulkarni, CEO of CRISPR Therapeutics here with us. CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
For more information on CRSP:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
EDIT is trading UP for the last 2 days, and it at trading at $5.43 with volume of 1,049,322 and a one day change of $0.11 (1.97%). Editas Medicine Inc has a 52-week low of 4.91 and a 52-week high of $11.90. The business's 50-day moving average price is $5.50 and its 200 day moving average price is $7.80. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 2.05.
For more information on EDIT:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
ALNY is trading UP for the last 3 days, and it at trading at $156.36 with volume of 496,764 and a one day change of $2.89 (1.88%). Alnylam Pharmaceuticals Inc has a 52-week low of 141.98 and a 52-week high of $218.88. The business's 50-day moving average price is $149.24 and its 200 day moving average price is $162.52. The firm has a market cap of $19 million, a P/E ratio of 0.00, and a beta of 0.30.
For more information on ALNY:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
REGN is trading UP for the last 2 days, and it at trading at $1,010.65 with volume of 332,381 and a one day change of $8.92 (0.89%). Regeneron Pharmaceuticals, Inc. has a 52-week low of 684.81 and a 52-week high of $1,016.00. The business's 50-day moving average price is $959.92 and its 200 day moving average price is $930.38. The firm has a market cap of $109 million, a P/E ratio of 28.73, and a beta of 0.12.
LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The FDA approves label expansion of Regeneron (REGN) and Sanofi's Kevzara for the treatment of polyarticular juvenile idiopathic arthritis. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 8:00 AM ET Company Participants Ryan Crowe - Head of IR Chris Fenimore - CFO Conference Call Participants Salveen Richter - Goldman Sachs Salveen Richter Good morning, everyone. Thank you for joining us and welcome to Day 2 of the Goldman Sachs Healthcare Conference. Approval in patients with pJIA weighing 63kg or greater adds to Kevzara's position in treating adult chronic inflammatory conditions of moderately to severely active rheumatoid arthritis and polymyalgia rheumatica
For more information on REGN:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
LH is trading UP for the last 1 days, and it at trading at $197.20 with volume of 346,053 and a one day change of $1.28 (0.65%). Laboratory Corp. Of America Holdings has a 52-week low of 186.63 and a 52-week high of $234.09. The business's 50-day moving average price is $201.97 and its 200 day moving average price is $214.03. The firm has a market cap of $17 million, a P/E ratio of 44.59, and a beta of 1.03.
For more information on LH:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
Top gainers in Biotechnology and Gene Therapy - CRSP, EDIT, ALNY, REGN, LH
By KlickAnalytics Data Insights | June 11, 2024 04:40PM ET
Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.
CRISPR Therapeutics AG (CRSP)
CRSP is trading UP for the last 2 days, and it at trading at $62.34 with volume of 1,770,869 and a one day change of $2.35 (3.92%). CRISPR Therapeutics AG has a 52-week low of 37.55 and a 52-week high of $91.10. The business's 50-day moving average price is $55.60 and its 200 day moving average price is $65.27. The firm has a market cap of $5 million, a P/E ratio of 14.17, and a beta of 1.78.
Top news headlines for CRSP
For more information on CRSP:
Editas Medicine Inc (EDIT)
EDIT is trading UP for the last 2 days, and it at trading at $5.43 with volume of 1,049,322 and a one day change of $0.11 (1.97%). Editas Medicine Inc has a 52-week low of 4.91 and a 52-week high of $11.90. The business's 50-day moving average price is $5.50 and its 200 day moving average price is $7.80. The firm has a market cap of $0 million, a P/E ratio of 0.00, and a beta of 2.05.
For more information on EDIT:
Alnylam Pharmaceuticals Inc (ALNY)
ALNY is trading UP for the last 3 days, and it at trading at $156.36 with volume of 496,764 and a one day change of $2.89 (1.88%). Alnylam Pharmaceuticals Inc has a 52-week low of 141.98 and a 52-week high of $218.88. The business's 50-day moving average price is $149.24 and its 200 day moving average price is $162.52. The firm has a market cap of $19 million, a P/E ratio of 0.00, and a beta of 0.30.
For more information on ALNY:
Regeneron Pharmaceuticals, Inc. (REGN)
REGN is trading UP for the last 2 days, and it at trading at $1,010.65 with volume of 332,381 and a one day change of $8.92 (0.89%). Regeneron Pharmaceuticals, Inc. has a 52-week low of 684.81 and a 52-week high of $1,016.00. The business's 50-day moving average price is $959.92 and its 200 day moving average price is $930.38. The firm has a market cap of $109 million, a P/E ratio of 28.73, and a beta of 0.12.
Top news headlines for REGN
For more information on REGN:
Laboratory Corp. Of America Holdings (LH)
LH is trading UP for the last 1 days, and it at trading at $197.20 with volume of 346,053 and a one day change of $1.28 (0.65%). Laboratory Corp. Of America Holdings has a 52-week low of 186.63 and a 52-week high of $234.09. The business's 50-day moving average price is $201.97 and its 200 day moving average price is $214.03. The firm has a market cap of $17 million, a P/E ratio of 44.59, and a beta of 1.03.
For more information on LH:
This article was generated by KlickAnalytics data insight content engine.
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.